Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254K Sell
6,736
-8,156
-55% -$344K ﹤0.01% 2095
2025
Q4
$770K Sell
14,892
-1,466
-9% -$89.6K ﹤0.01% 1371
2025
Q3
$1.22M Buy
16,358
+4,115
+34% +$302K 0.01% 993
2025
Q2
$936K Sell
12,243
-728
-6% -$52.4K 0.01% 1015
2025
Q1
$921K Buy
12,971
+2,007
+18% +$139K 0.01% 869
2024
Q4
$685K Sell
10,964
-1,601
-13% -$105K 0.01% 927
2024
Q3
$744K Buy
12,565
+2,972
+31% +$163K 0.01% 691
2024
Q2
$545K Buy
+9,593
New +$589K 0.02% 508

Other funds holding NTNX

&Partners's NTNX Position: Q1 2026 in Review

&Partners reduced its Nutanix (NTNX) stake by 55% in Q1 2026, selling an estimated $344K and leaving 6,736 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

&Partners first reported a position in NTNX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.22M in Q3 2025. 533 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • &Partners held 6,736 shares of Nutanix worth $254K as of Q1 2026.
  • &Partners sold 8,156 Nutanix shares in Q1 2026, an estimated $344K.
  • Nutanix made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #2095 holding.
  • &Partners first reported a position in Nutanix in Q2 2024 and has held it in 8 quarters since.
  • &Partners's Nutanix position peaked at $1.22M in Q3 2025.
  • 533 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.